Abstract
The initial presentation of cardiac sarcoidosis (CS) may be in the acute care setting with heart block, ventricular tachycardia (VT) or acute heart failure (HF). Cardiovascular clinicians should consider sarcoidosis in the differential diagnosis when confronting these relatively common problems, especially where the patient is relatively young and once coronary heart disease has been excluded. Corticosteroids are the principal immunosuppressant used in the acute setting, owing to its relatively rapid effect. Although minimal controlled data are available to guide the use of corticosteroids, they have been most effective in resolving AV block. Accordingly, conventional management of VT and HF should be also be utilized.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305–23.
Diagnostic standard and guidelines for sarcoidosis. Jpn J Sarcoidosis Granulomatous Disord. 2007;27:89–102.
Judson MA, Costabel U, Drent M, et al. The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31:19–27.
Nery PB, Beanlands RS, Nair GM, et al. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults. J Cardiovasc Electrophysiol. 2014;25:875–81.
Koplan BA, Soejima K, Baughman K, Epstein LM, Stevenson WG. Refractory ventricular tachycardia secondary to cardiac sarcoidosis: electrophysiologic characteristics, mapping, and ablation. Heart Rhythm. 2006;3:924–9.
Nery PB, Mc Ardle BA, Redpath CJ, Leung E, Lemery R, Dekemp R, Yang J, Keren A, Beanlands RS, Birnie DH. Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia. Pacing Clin Electrophysiol. 2014;37:364–74.
Hershberger RE, Siegfried JD. Update 2011: clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol. 2011;57:1641–9.
Lakdawala NK, Givertz MM. Dilated cardiomyopathy with conduction disease and arrhythmia. Circulation. 2010;122:527–34.
Saffitz JE. Arrhythmogenic cardiomyopathy: advances in diagnosis and disease pathogenesis. Circulation. 2011;124:e390–2.
Lakdawala NK, Funke BH, Baxter S, et al. Genetic testing for dilated cardiomyopathy in clinical practice. J Card Fail. 2012;18:296–303.
Lakdawala NK. Using genetic testing to guide therapeutic decisions in cardiomyopathy. Curr Treat Options Cardiovasc Med. 2013;15:387–96.
Fox MC, Lakdawala N, Miller AL, Loscalzo J. Clinical problem-solving. A patient with syncope. N Engl J Med. 2013;369:966–72.
Viotti R, Vigliano C, Lococo B, Bertocchi G, Petti M, Alvarez MG, Postan M, Armenti A. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Ann Intern Med. 2006;144:724–34.
Lattes R, Lasala MB. Chagas disease in the immunosuppressed patient. Clin Microbiol Infect. 2014;20:300–9.
Lee JC, Seiler J, Blankstein R, Padera RF, Baughman KL, Tedrow UB. Images in cardiovascular medicine. Cardiac sarcoidosis presenting as heart block. Circulation. 2009;120:1550–1.
Nery PB, Keren A, Healey J, Leug E, Beanlands RS, Birnie DH. Isolated cardiac sarcoidosis: establishing the diagnosis with electroanatomic mapping-guided endomyocardial biopsy. Can J Cardiol. 2013;29:1015.e1–3.
Sadek MM, Yung D, Birnie DH, Beanlands RS, Nery PB. Corticosteroid therapy for cardiac sarcoidosis: a systematic review. Can J Cardiol. 2013;29:1034–41.
Jefic D, Joel B, Good E, Morady F, Rosman H, Knight B, Bogun F. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry. Heart Rhythm. 2009;6:189–95.
Tokuda M, Tedrow UB, Kojodjojo P, Inada K, Koplan BA, Michaud GF, John RM, Epstein LM, Stevenson WG. Catheter ablation of ventricular tachycardia in nonischemic heart disease. Circ Arrhythm Electrophysiol. 2012;5:992–1000.
Chiu C-Z, Nakatani S, Zhang G, Tachibana T, Ohmori F, Yamagishi M, Kitakaze M, Tomoike H, Miyatake K. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol. 2005;95:143–6.
Blankstein R, Osborne M, Naya M, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol. 2014;63:329–36.
Osborne M, Kolli S, Padera RF, Naya M, Lewis E, Dorbala S, Di Carli MF, Blankstein R. Use of multimodality imaging to diagnose cardiac sarcoidosis as well as identify recurrence following heart transplantation. J Nucl Cardiol. 2013;20:310–2.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Lakdawala, N.K., Stewart, G.C. (2015). Acute Management of Cardiac Sarcoidosis. In: Freeman, A., Weinberger, H. (eds) Cardiac Sarcoidosis. Springer, Cham. https://doi.org/10.1007/978-3-319-14624-9_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-14624-9_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-14623-2
Online ISBN: 978-3-319-14624-9
eBook Packages: MedicineMedicine (R0)